Moleculin Biotech, Inc. (NASDAQ:MBRX) Q4 2024 Earnings Call Transcript March 24, 2025
Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full Year 2024 Update Conference Call and Webcast. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. At this time, I’d like to remind our listeners that remarks made during this webcast may state management’s intentions, beliefs, expectations, or future projections....
